We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Geron
GERN
$784M
| $72K | ﹤0.01% |
48,319
+5,398
| +13% | +$8.21K |
2021 Q2
19 quarters
|
|
1602
Butterfly Network
BFLY
$2.27B
| $71.9K | ﹤0.01% |
17,803
+2,509
| +16% | +$9.69K |
2025 Q2
3 quarters
|
|
1603
Savara
SVRA
$999M
| $69.6K | ﹤0.01% |
12,746
+1,756
| +16% | +$9.77K |
2025 Q4
1 quarter
|
|
1604
Redwood Trust
RWT
$389M
| $69.1K | ﹤0.01% |
12,323
+1,519
| +14% | +$8.81K |
2023 Q2
11 quarters
|
|
1605
DELISTED
Talkspace
TALK
| $67.7K | ﹤0.01% |
13,075
+1,806
| +16% | +$7.99K |
2025 Q3
2 quarters
|
|
1606
MannKind Corp
MNKD
$997M
| $67.3K | ﹤0.01% |
27,486
+3,668
| +15% | +$16.4K |
2021 Q2
19 quarters
|
|
1607
DELISTED
American Express Global Business Travel
GBTG
| $66.8K | ﹤0.01% |
11,963
-1,453
| -11% | -$9.02K |
2024 Q4
5 quarters
|
|
1608
Empire State Realty Trust
ESRT
$809M
| $65.8K | ﹤0.01% |
12,662
+1,426
| +13% | +$8.56K |
2025 Q1
4 quarters
|
|
1609
LegalZoom.com
LZ
$1.03B
| $65.6K | ﹤0.01% |
11,572
+1,495
| +15% | +$11.3K |
2025 Q4
1 quarter
|
|
1610
BrightSpire Capital
BRSP
$485M
| $65.2K | ﹤0.01% |
11,649
+1,547
| +15% | +$8.96K |
2025 Q3
2 quarters
|
|
1611
Ambev
ABEV
$49.8B
| $65K | ﹤0.01% |
22,266
+2,489
| +13% | +$7.11K |
2025 Q1
4 quarters
|
|
1612
Clover Health Investments
CLOV
$2.52B
| $65K | ﹤0.01% |
36,915
+4,900
| +15% | +$10.6K |
2025 Q2
3 quarters
|
|
1613
ACV Auctions
ACVA
$1.77B
| $64.4K | ﹤0.01% |
15,190
+2,014
| +15% | +$13.2K |
2024 Q4
5 quarters
|
|
1614
Ardagh Metal Packaging
AMBP
$2.59B
| $64.4K | ﹤0.01% |
15,896
+1,672
| +12% | +$7.41K |
2024 Q4
5 quarters
|
|
1615
CEMIG Preferred Shares
CIG
$6.92B
| $64.4K | ﹤0.01% |
26,930
+2,443
| +10% | +$5.38K |
2024 Q2
7 quarters
|
|
1616
Clarivate
CLVT
$1.01B
| $64.3K | ﹤0.01% |
25,413
+7,097
| +39% | +$18.2K |
2022 Q4
13 quarters
|
|
1617
Stagwell
STGW
$2.11B
| $63.7K | ﹤0.01% |
+10,126
| New | +$56.6K |
2026 Q1
0 quarters
|
|
1618
Janus International
JBI
$574M
| $63.4K | ﹤0.01% |
12,306
+1,626
| +15% | +$10.5K |
2024 Q4
5 quarters
|
|
1619
Precigen
PGEN
$2.77B
| $63.3K | ﹤0.01% |
16,352
+2,161
| +15% | +$8.87K |
2025 Q2
3 quarters
|
|
1620
SELLAS Life Sciences
SLS
$2.42B
| $62.7K | ﹤0.01% |
+14,817
| New | +$66.3K |
2026 Q1
0 quarters
|
|
1621
Compass Therapeutics
CMPX
$168M
| $62.6K | ﹤0.01% |
11,836
+1,635
| +16% | +$9.44K |
2025 Q4
1 quarter
|
|
1622
Annexon
ANNX
$758M
| $62.1K | ﹤0.01% |
+11,206
| New | +$63.1K |
2026 Q1
0 quarters
|
|
1623
Arbutus Biopharma
ABUS
$826M
| $61.6K | ﹤0.01% |
13,690
+1,814
| +15% | +$7.93K |
2024 Q4
5 quarters
|
|
1624
PureCycle Technologies
PCT
$733M
| $61.2K | ﹤0.01% |
11,783
+1,557
| +15% | +$13K |
2025 Q2
3 quarters
|
|
1625
Sprinklr
CXM
$1.28B
| $60.9K | ﹤0.01% |
+10,155
| New | +$63K |
2026 Q1
0 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.